Intuitive Surgical, Inc. $ISRG Shares Sold by Carmignac Gestion

Carmignac Gestion decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.0% during the first quarter, Holdings Channel.com reports. The firm owned 29,870 shares of the medical equipment provider’s stock after selling 2,598 shares during the period. Carmignac Gestion’s holdings in Intuitive Surgical were worth $14,776,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in ISRG. AlphaCore Capital LLC increased its holdings in Intuitive Surgical by 4.2% in the fourth quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider’s stock worth $235,000 after buying an additional 18 shares during the last quarter. Second Line Capital LLC boosted its position in shares of Intuitive Surgical by 3.4% in the fourth quarter. Second Line Capital LLC now owns 578 shares of the medical equipment provider’s stock valued at $302,000 after acquiring an additional 19 shares during the period. Colonial Trust Co SC lifted its position in Intuitive Surgical by 8.8% in the fourth quarter. Colonial Trust Co SC now owns 246 shares of the medical equipment provider’s stock worth $128,000 after purchasing an additional 20 shares during the period. Crown Wealth Group LLC lifted its position in Intuitive Surgical by 4.8% in the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock worth $218,000 after purchasing an additional 20 shares during the period. Finally, FSM Wealth Advisors LLC raised its stake in Intuitive Surgical by 3.8% during the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock worth $270,000 after acquiring an additional 20 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Gary S. Guthart sold 2,800 shares of the business’s stock in a transaction on Monday, July 28th. The shares were sold at an average price of $495.24, for a total value of $1,386,672.00. Following the completion of the sale, the insider owned 18,520 shares in the company, valued at approximately $9,171,844.80. The trade was a 13.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 15,839 shares of company stock valued at $7,896,972. Company insiders own 0.70% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG opened at $481.28 on Tuesday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The company has a market capitalization of $172.53 billion, a price-to-earnings ratio of 67.12, a price-to-earnings-growth ratio of 5.03 and a beta of 1.59. The business has a 50-day moving average of $507.85 and a 200-day moving average of $524.14.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The company had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same period last year, the company earned $1.78 earnings per share. The firm’s revenue was up 21.4% compared to the same quarter last year. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts recently commented on the company. Barclays lowered their price objective on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a research report on Thursday, April 24th. Wells Fargo & Company boosted their target price on Intuitive Surgical from $559.00 to $599.00 and gave the company an “overweight” rating in a research note on Wednesday, July 23rd. Erste Group Bank restated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. UBS Group boosted their target price on Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research note on Wednesday, July 23rd. Finally, Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Saturday, July 26th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $595.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.